Data Foundry

Drug recalls 2019

Pramipexole Dihydrochloride Tablets 1 mg — Class II drug recall D-1447-2019

Terminated recall by Zydus Pharmaceuticals USA Inc, reported 2019-06-26, distributed nationwide. CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Recall numberD-1447-2019
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmZydus Pharmaceuticals USA Inc, Pennington, NJ, United States
Recall initiated2019-05-06
Classified2019-07-01
Reported by FDA2019-06-26
Terminated2021-09-16
DistributedNationwide (US)
Reason classescgmp
NDC68382-0199-16
Lot numbersAUG-20, DEC-19, JUL-20, M714186, M714187, M714188, M714903, M714904, M714905, M715586, M715587, M801441, M801442, M801443, M801444, M801445, M811152, M811153, M811154, M811155, M811156, M814298, M814299, M814300, M814301, M814302, M818136, M818137, M818138, M818139, M818140, NOV-19, NOV-20, OCT-19

Product

Pramipexole Dihydrochloride Tablets 1 mg, 90-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-199-16

Reason for recall

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1447-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.